HUMAN FAECAL MATTER
Diarrhea
M.D. Anderson Cancer Centerother_biologicalPhase 1Active
CC
43/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 28/ 100
- Competitive Position
- 95/ 100
Competitive context
3 Active assets in the Diarrhea cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Octreotide Pamoate University of Southern California | Phase 3 | BB |
Irinotecan Roswell Park Cancer Institute | Phase 3 | BB |
Loperamide Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | Phase 3 | BB |
NEPENTHE Federal University of Minas Gerais | Phase 4 | BB |
DEXKETOPROFEN Federal University of Minas Gerais | Phase 4 | BB |
View all 26 →
Same molecule, other indications
HUMAN FAECAL MATTER is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →